Physician profile
Eric M Johnson
NPI 1528089174
$8,015.01
in general payments reported to CMS, 2019-2025
66 companies · $1,637 in 2025
The $1,637 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $737 · 2021: $848 · 2022: $629 · 2023: $1,387 · 2024: $1,519 · 2025: $1,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,411 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,411.16 |
| Education | $132.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,133.71 | 2020-2025 | |
| Aimmune Therapeutics, INC. | $524.97 | 2024 | |
| Novo Nordisk INC | $498.30 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $477.95 | 2021-2025 | |
| Lilly USA, LLC | $474.63 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $400.31 | 2019-2025 | Evenity, Prolia, Repatha |
| Supernus Pharmaceuticals, INC. | $369.72 | 2019-2022 | |
| Astellas Pharma US INC | $340.11 | 2019-2025 | Veozah, Myrbetriq |
| Allergan, INC. | $307.10 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $306.44 | 2019-2025 | Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $216.77 | 2022-2025 | |
| Abbott Laboratories | $190.25 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Otsuka America Pharmaceutical, INC. | $177.12 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $173.94 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.91 | 2019-2025 | Trintellix |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.